Charles York
Director of Finance/CFO bij DAY ONE BIOPHARMACEUTICALS, INC.
Vermogen: 5 M $ op 31-03-2024
Profiel
Charles N.
York is currently the Chief Operating & Financial Officer at DOT Therapeutics-2, Inc. and the Chief Operating & Financial Officer, Secretary at Day One Biopharmaceuticals, Inc. Previously, he worked as the Controller at Astrotech Corp.
from 2009 to 2012 and as the Chief Financial Officer, Secretary & VP at Spyre Therapeutics, Inc. from 2014 to 2021.
Mr. York obtained his undergraduate degree from the University of Connecticut in 1999 and his MBA from the McCombs School of Business in 2006.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2024 | 277 754 ( 0.32% ) | 5 M $ | 31-03-2024 |
Actieve functies van Charles York
| Bedrijven | Functie | Begin |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | 01-02-2021 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 17-02-2021 |
Eerdere bekende functies van Charles York
| Bedrijven | Functie | Einde |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director of Finance/CFO | 12-02-2021 |
| ASTROTECH CO. | Comptroller/Controller/Auditor | 01-08-2012 |
Opleiding van Charles York
| University of Connecticut | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ASTROTECH CO. | Electronic Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
